Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Am J Phys Med Rehabil. 2013 Mar;92(3):203–214. doi: 10.1097/PHM.0b013e31827446eb

Table 1. Baseline characteristics of overall cohort.

N (%) Average cost ($) Average LOS (days)
Overall 1,536 45,183 30.8
PATIENT-LEVEL
Demographics
 Overall average age (SD) 68.15 (11.04)
 Gender
  Male 1519 (98.89) 45,085 30.9
  Female 17 (1.11) 53,958 28.9
 Marital status
  Married 712 (46.35) 42,277 27.0
  Not married 824 (53.65) 47,694 34.2
Living location before hospitalization
 Extended care 182 (11.85) 24,814 15.3
 Home 1296 (84.38) 47,444 32.4
 Hospital 58 (3.78) 58,575 45.2
Amputation level
 Unilateral trans-tibial 477 (31.05) 43,367 29.1
 Unilateral trans-femoral 388 (25.26) 46,241 30.0
 Bilateral trans-tibial 24 (1.56) 27,359 19.6
 Bilateral trans-femoral 647 (42.12) 46,549 33.0
Amputation etiologies
 Chronic osteomyelitis 96 (6.25) 39,224 25.5
 Device infection 165 (10.74) 60,470 33.1
 Diabetes mellitus type I 257 (16.73) 48,761 28.8
 Diabetes mellitus type II 975 (63.48) 41,145 29.3
 Local significant infection 1201 (78.19) 42,751 29.3
 Peripheral vascular disease 1340 (87.24) 43,713 28.9
 Previous amputation complication 116 (7.55) 49,058 36.8
 Skin breakdown 981 (63.87) 43,005 31.1
 Systemic sepsis 185 (12.04) 66,359 40.2
 Trauma 202 (13.15) 50,484 31.3
Comorbidities
 AIDS 11 (0.72) 55,333 24.3
 Alcohol abuse 81 (5.27) 51,475 30.2
 Arrhythmias 272 (17.71) 48,510 30.7
 Chronic blood loss anemia 36 (2.34) 93,601 91.5
 Chronic pulmonary disease 324 (21.09) 50,131 37.0
 Coagulopathy 66 (4.30) 68,740 33.2
 Congestive heart failure 364 (23.70) 43,439 29.4
 Deficiency anemias 280 (18.23) 45,120 32.2
 Depression 134 (8.72) 47,959 37.0
 Drug abuse 25 (1.63) 42,071 23.6
 Fluid and electrolyte disorders 298 (19.40) 51,968 37.1
 Hypertension 880 (57.29) 39,477 28.3
 Hypertension with complication 9 (0.59) 43,659 26.1
 Hypothyroidism 58 (3.78) 35,194 23.6
 Liver disease 52 (3.39) 46,129 28.9
 Lymphoma 8 (0.52) 32,797 20.4
 Metastatic cancer 25 (1.63) 67,733 32.2
 Other neurological disorders 54 (3.52) 42,876 24.4
 Paralysis 72 (4.69) 84,927 83.3
 Peptic ulcer 22 (1.43) 30,518 21.8
 Psychoses 112 (7.29) 45,231 38.6
 Pulmonary circulation disease 14 (0.91) 63,776 32.1
 Renal failure 277 (18.03) 48,280 27.3
 Rheumatoid arthritis 22 (1.43) 22,873 17.4
 Solid tumor without metastasis 109 (7.1) 58,307 27.5
 Valvular disease 64 (4.17) 50,606 30.9
 Weight loss 79 (5.14) 52,892 38.5
TYPE OF INPATIENT REHABILITATION
 No evidence 697 (45.38) 44,651 31.4
 Consultative 668 (43.49) 43,524 28.1
 Specialized 171 (11.13) 53,831 39.2
FACILITY-LEVEL
 Geographic region
  Northeast 262 (17.06) 55,951 37.4
  Southeast 455 (29.62) 40,325 33.4
  Midwest 268 (17.45) 38,136 22.0
  South Central 340 (22.14) 41,304 29.2
  Mountain Pacific 211 (13.74) 57,488 31.1
 Total bed size
  Bed size ≤ 126 433 (28.19) 34,518 20.1
  Bed size 127-244 443 (28.84) 44,435 27.8
  Bed size 245-362 529 (34.44) 52,553 39.6
  Bed size > 362 131 (8.53) 53,202 41.4
 CARF accreditation 763 (49.67) 53,960 36.0
  No CARF accreditation 773 (50.33) 36,520 25.7

CARF = Commission on Accreditation of Rehabilitation Facilities